AFCs are characterised by typical environmental problems such as 432 changes in land use, CO2 emissions, energy and water consumption, and chemical pollution. Recent technological changes in the agri-food industry have influenced the economic and social development of AFCs towards progressive industrialization. Such changes
have also been the source of new environmental problems, such as those related to the large-scale use and disposal of auxiliary materials. Industrial Ecology (IE) proposes approaches and applied solutions to reduce the environmental impacts and improve the competitiveness of production activities. Major applications of IE in AFCs currently involve the valorisation of animal and vegetable by-products and scraps. Further
improvements can be achieved by adopting IE-based solutions focused on auxiliary material wastes. This article analyses Entinostat price the potential development of IE-based approaches in a representative Italian AFC. Empirical evidence shows that efficient solutions can be implemented through material substitution, repair, and recycling, and by exploiting collaborative strategies among the agri-food Torin 2 manufacturer and industrial companies established in the area. (C) 2015 Elsevier B.V. All rights reserved.”
“Introduction: Organic anion transporting polypeptide (OATP) uptake transporters are important for the disposition of many drugs and perturbed OATP activity can contribute to adverse drug reactions (ADRs). It is well documented that both genetic and environmental factors can alter OATP expression and activity. Genetic factors include single nucleotide polymorphisms (SNPs) that change OATP activity and epigenetic regulation that modify OATP expression levels. SNPs in OATPs contribute to
ADRs. Environmental factors include the pharmacological context of drug-drug interactions and the physiological context of liver diseases. Liver diseases such as nonalcoholic fatty liver disease, cholestasis and hepatocellular carcinoma change the expression of multiple OATP isoforms. The role of liver diseases in the occurrence of ADRs is unknown.\n\nAreas covered: This article covers the roles OATPs play in ADRs when considered in the context of genetic or environmental factors. The reader will gain RG-7388 a greater appreciation for the current evidence regarding the salience and importance of each factor in OATP-mediated ADRs.\n\nExpert opinion: A SNP in a single OATP transporter can cause changes in drug pharmacokinetics and contribute to ADRs but, because of overlap in substrate specificities, there is potential for compensatory transport by other OATP isoforms. By contrast, the expression of multiple OATP isoforms is decreased in liver diseases, reducing compensatory transport and thereby increasing the probability of ADRs.